LifeTech Scientific Corporation (01302) said its net profit attributable to owners for the year ended 31 December 2016 rose surged 60.74 times year-on-year to Rmb146 million.
Basic and diluted earnings per share were Rmb3.6 cents.
The revenue was Rmb353 million, an increase of 13.2% from a year earlier.
The gross profit grew 9.5% year-on-year to Rmb276.5 million. Gross profit margin decreased by 2.7 percentage points to 78.4%.
The increase in net profit was mainly attributable to the growth of sales and operating profit; and the gain on disposal of a subsidiary.
No final dividend will be distributed.
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情
